arrow
N

N. Magy-Bertrand

chu de nancy
H指数:25
被引数:2,787

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Effectiveness and Safety of Fostamatinib in Difficult-to-Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in France
2026-01-010
PRE
Clinical profiles associated with rapidly progressive interstitial lung disease in antisynthetase syndrome: A multicentric cohort study (TYPASS study)

与快速进展型间质性肺病相关的抗合成酶综合征临床特征:一项多中心队列研究(TYPASS研究)

2025-12-100
OAAI
Assessment of internship sites in Internal Medicine and Clinical Immunology, 7 years after the Residency Training Program Reform: Findings from a 2024 year-end survey in France

内科和临床免疫学实习基地评估:住院医师培训计划改革7年后的调查结果——来自法国2024年度末调查

2025-09-010
PRE
Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome

VEXAS综合征中自然杀伤细胞的细胞毒性功能受损及耗竭表型

Blood
IF23.1
2025-07-310
PRE
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases
2023-04-0127
OAAI
Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients
2021-11-28222
OA
Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study

200系统性红斑狼疮伴或不伴狼疮性肾炎患者缺乏抗肾小球基底膜抗体: GOODLUPUS研究的结果

2020-12-143
OAAI
Infliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis: Results of a multicenter open-label prospective study
2020-10-0115
OAAI
Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations
2020-07-0212
OAAI
Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia

抗血小板抗体不能预测免疫性血小板减少症期间对静脉内免疫球蛋白的反应

2020-06-2511
OAAI
HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome
2018-12-0167
PREAI
Prevalence of autoantibodies in the course of Gaucher disease type 1: A multicenter study comparing Gaucher disease patients to healthy subjects
2018-01-018
PREAI